$ELA
Envela Corp Stock $ela

$ela Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000165495422003269 Filed on March 16, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$44.07M	$141.0M	$28.74M
YoY Change	53.36%	23.74%	29.41%
Cost Of Revenue	$34.39M	$21.72M	$22.60M
YoY Change	52.15%	33.43%	35.18%
Gross Profit	$9.679M	$31.22M	$6.133M
YoY Change	57.82%	35.34%	11.8%
Gross Profit Margin	21.96%	22.15%	21.34%
Selling, General & Admin	$6.583M	$20.80M	$4.242M
YoY Change	55.2%	33.72%	1.4%
% of Gross Profit	68.02%	66.62%	69.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$288.8K	$926.1K	$189.4K
YoY Change	52.47%	27.1%	-35.3%
% of Gross Profit	2.98%	2.97%	3.09%
Operating Expenses	$6.872M	$21.72M	$4.431M
YoY Change	55.08%	33.43%	-1.0%
Operating Profit	$2.807M	$9.497M	$1.702M
YoY Change	64.93%	39.93%	68.58%
Interest Expense	-$158.5K	$704.1K	-$175.1K
YoY Change	-9.49%	13.47%	0.52%
% of Operating Profit	-5.65%	7.41%	-10.29%
Other Income/Expense, Net	$94.17K	-$299.4K	$186.5K
YoY Change	-49.5%	-197.54%	-4216.78%
Pretax Income	$2.804M	$10.16M	$1.713M
YoY Change	63.66%	56.97%	106.21%
Income Tax	$22.90K	$112.8K	$54.49K
% Of Pretax Income	0.82%	1.11%	3.18%
Net Earnings	$2.781M	$10.05M	$1.659M
YoY Change	67.66%	57.41%	107.07%
Net Earnings / Revenue	6.31%	7.13%	5.77%
Basic Earnings Per Share		$0.37
Diluted Earnings Per Share	$103.2K	$0.37	$61.61K
COMMON SHARES
Basic Shares Outstanding	26.92M shares	26.92M shares
Diluted Shares Outstanding		26.94M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.14M	$10.14M	$9.218M
YoY Change	9.98%	9.98%	104.36%
Cash & Equivalents	$10.14M	$10.14M	$9.218M
Short-Term Investments
Other Short-Term Assets	$969.6K	$3.013M	$0.00
YoY Change		109.44%	-100.0%
Inventory	$14.05M	$14.05M	$10.01M
Prepaid Expenses	$439.0K		$281.7K
Receivables	$7.167M	$7.167M	$2.847M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$34.37M	$34.37M	$23.51M
YoY Change	46.18%	46.18%	28.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.806M	$15.50M	$6.889M
YoY Change	42.35%	48.86%	86.88%
Goodwill	$6.140M		$1.367M
YoY Change	349.16%		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$237.8K	$237.8K	$197.6K
YoY Change	20.3%	20.3%	-3.49%
Total Long-Term Assets	$24.90M	$24.90M	$17.07M
YoY Change	45.89%	45.89%	97.28%
TOTAL ASSETS
Total Short-Term Assets	$34.37M	$34.37M	$23.51M
Total Long-Term Assets	$24.90M	$24.90M	$17.07M
Total Assets	$59.27M	$59.27M	$40.58M
YoY Change	46.05%	46.05%	50.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.488M	$2.488M	$1.511M
YoY Change	64.72%	64.72%	2.92%
Accrued Expenses	$1.789M	$3.254M	$844.3K
YoY Change	111.93%	74.38%	-59.63%
Deferred Revenue
YoY Change
Short-Term Debt	$1.700M	$1.700M	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$2.766M	$1.066M	$2.120M
YoY Change	30.43%	-49.74%
Total Short-Term Liabilities	$9.797M	$9.797M	$6.053M
YoY Change	61.85%	61.85%	25.86%
LONG-TERM LIABILITIES
Long-Term Debt	$15.97M	$15.97M	$13.29M
YoY Change	20.14%	20.14%	55.39%
Other Long-Term Liabilities	$5.873M	$5.873M	$3.654M
YoY Change	60.71%	60.71%	49.45%
Total Long-Term Liabilities	$15.97M	$21.84M	$13.29M
YoY Change	20.14%	28.89%	20.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.797M	$9.797M	$6.053M
Total Long-Term Liabilities	$15.97M	$21.84M	$13.29M
Total Liabilities	$31.64M	$31.64M	$23.00M
YoY Change	37.56%	37.56%	45.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.81M		-$22.86M
YoY Change	-43.95%
Common Stock	$40.44M		$40.44M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.63M	$27.63M	$17.58M
YoY Change
Total Liabilities & Shareholders Equity	$59.27M	$59.27M	$40.58M
YoY Change	46.05%	46.05%	50.27%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$2.781M	$10.05M	$1.659M
YoY Change	67.66%	57.41%	107.07%
Depreciation, Depletion And Amortization	$288.8K	$926.1K	$189.4K
YoY Change	52.47%	27.1%	-35.3%
Cash From Operating Activities	$1.779M	$2.805M	$3.662M
YoY Change	-51.44%	-59.33%	67.26%
INVESTING ACTIVITIES
Capital Expenditures	-$74.44K	$3.139M	-$3.982M
YoY Change	-98.13%	-46.48%	26446.67%
Acquisitions		$13.14K
YoY Change
Other Investing Activities	-$1.450M	-$1.737M	-$600.0K
YoY Change	141.63%	-17.3%
Cash From Investing Activities	-$1.524M	-$4.875M	-$4.582M
YoY Change	-66.73%	-38.79%	30446.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.561M	$2.990M	2.868M
YoY Change	-45.59%	-48.22%	-1407.49%
NET CHANGE
Cash From Operating Activities	1.779M	$2.805M	3.662M
Cash From Investing Activities	-1.524M	-$4.875M	-4.582M
Cash From Financing Activities	1.561M	$2.990M	2.868M
Net Change In Cash	1.815M	$920.1K	1.949M
YoY Change	-6.87%	-80.45%	-0.33%
FREE CASH FLOW
Cash From Operating Activities	$1.779M	$2.805M	$3.662M
Capital Expenditures	-$74.44K	$3.139M	-$3.982M
Free Cash Flow	$1.853M	-$333.7K	$7.644M
YoY Change	-75.76%	-132.31%	246.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	728626	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	21724190	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	969624	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	439038	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	281719	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	926095	USD
CY2021	dei	Auditor Firm AuditorFirmId	726
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	140966078	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113922015	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	109744919	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	90853052	USD
CY2021	us-gaap	Gross Profit GrossProfit	31221159	USD
CY2020	us-gaap	Gross Profit GrossProfit	23068963	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20798095	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15553274	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	16281900	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	9496969	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	6787063	USD
CY2021	ela	Other Income From Loan Forgiveness OtherIncomeFromLoanForgiveness	1668200	USD
CY2020	ela	Other Income From Loan Forgiveness OtherIncomeFromLoanForgiveness	0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-299435	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	306997	USD
CY2021	us-gaap	Interest Expense InterestExpense	704051	USD
CY2020	us-gaap	Interest Expense InterestExpense	620499	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	10161683	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6473561	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112808	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89618	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	10048875	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	6383943	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26924631	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26924631	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26939631	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26939631	shares
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10138148	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9218036	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7166533	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2846619	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	14048436	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10006897	USD
CY2021Q4	ela	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	1604736	USD
CY2020Q4	ela	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	1157077	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	0	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	34366515	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	23510348	USD
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2100000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9806188	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6888601	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	411850	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	387000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	381500	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	381500	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1014895	USD
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1065794	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1813425	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1573824	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1148309	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1789366	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	844324	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1179224	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	428976	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9796604	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6052763	USD
CY2021	ela	Write Off Of Note Receivables And Accrued Interest Receivable WriteOffOfNoteReceivablesAndAccruedInterestReceivable	-887821	USD
CY2021Q4	us-gaap	Goodwill Goodwill	6140465	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1367109	USD
CY2021Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	3024245	USD
CY2020Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	2992473	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5692141	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3522923	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	237761	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	197638	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	59267315	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40579092	USD
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2488396	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1510697	USD
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	307032	USD
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	1700000	USD
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	9052810	USD
CY2021Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	15970337	USD
CY2020Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	4240658	USD
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	5873057	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	3654419	USD
CY2021Q4	us-gaap	Liabilities Liabilities	31639998	USD
CY2020Q4	us-gaap	Liabilities Liabilities	23000650	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	269246	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	269246	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	40173000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	40173000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12814929	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22863804	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	27627317	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	17578442	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59267315	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40579092	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	10048875	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	6383943	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	926095	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	728626	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	325	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-83003	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2021	ela	Gain On Forgiveness Of Federal Loan GainOnForgivenessOfFederalLoan	1668200	USD
CY2020	ela	Gain On Forgiveness Of Federal Loan GainOnForgivenessOfFederalLoan	0	USD
CY2020	ela	Write Off Of Note Receivables And Accrued Interest Receivable WriteOffOfNoteReceivablesAndAccruedInterestReceivable	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3969701	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	151124	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3554802	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-497444	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-60996	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-108884	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1024234	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7145	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-752379	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	29332	USD
CY2021	ela	Increase Decrease In Operating Leases IncreaseDecreaseInOperatingLeases	-27275	USD
CY2020	ela	Increase Decrease In Operating Leases IncreaseDecreaseInOperatingLeases	1984	USD
CY2021	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-357548	USD
CY2020	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-263572	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2805063	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6897091	USD
CY2021	ela	Investment In Note Receivable InvestmentInNoteReceivable	-300000	USD
CY2020	ela	Investment In Note Receivable InvestmentInNoteReceivable	-2100000	USD
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	61353	USD
CY2020	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3138715	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5864588	USD
CY2021	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	1511130	USD
CY2021	ela	Acquisition Of Cexchange Assets Net Of Cash Acquired AcquisitionOfCexchangeAssetsNetOfCashAcquired	-13136	USD
CY2020	ela	Acquisition Of Cexchange Assets Net Of Cash Acquired AcquisitionOfCexchangeAssetsNetOfCashAcquired	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4875356	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7964588	USD
CY2021	ela	Payments On Notes Payable Related Party PaymentsOnNotesPayableRelatedParty	-268793	USD
CY2020	ela	Payments On Notes Payable Related Party PaymentsOnNotesPayableRelatedParty	-279210	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	212802	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	26117	USD
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1700000	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2021	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	0	USD
CY2020	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	1668200	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1772000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	4412000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2990405	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5774873	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	920112	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4707376	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9218036	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4510660	USD
CY2021	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10138148	USD
CY2020	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9218036	USD
CY2021	us-gaap	Interest Paid InterestPaid	688391	USD
CY2020	us-gaap	Interest Paid InterestPaid	620499	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	86000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	59025	USD
CY2021	ela	Acquisition Of Cexchange Assets And Liabilities Through Forgiveness Of Debt AcquisitionOfCexchangeAssetsAndLiabilitiesThroughForgivenessOfDebt	1555892	USD
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	9091049	USD
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	11194174	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	325	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	6383943	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	17578442	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	10048875	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	27627317	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	81420	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	37798	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1583	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	140966078	USD
CY2021	us-gaap	Gross Profit GrossProfit	31221159	USD
CY2021	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.221	pure
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113922015	USD
CY2020	us-gaap	Gross Profit GrossProfit	23068963	USD
CY2020	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.202	pure
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Examples of estimates and assumptions include: for revenue recognition, determining the nature and timing of satisfaction of performance obligations, and determining the standalone selling price of performance obligations, variable consideration, and other obligations such as product returns and refunds; loss contingencies; the fair value of and/or potential impairment of goodwill and intangible assets for our reporting units; useful lives of our tangible and intangible assets; allowances for doubtful accounts; valuation allowance; the market value of, and demand for, our inventory and the potential outcome of uncertain tax positions that have been recognized on our consolidated financial statements or tax returns. Actual results and outcomes may differ from management’s estimates and assumptions.</p>
CY2021Q4	us-gaap	Inventory Net InventoryNet	14048436	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10006897	USD
CY2021Q4	ela	Partial Notes And Loans Receivable Net Current PartialNotesAndLoansReceivableNetCurrent	61353	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9806188	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6888601	USD
CY2021	us-gaap	Depreciation Depreciation	498866	USD
CY2020	us-gaap	Depreciation Depreciation	327026	USD
CY2021Q4	ela	Partial Notes And Loans Receivable Net Current PartialNotesAndLoansReceivableNetCurrent	61353	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1367109	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1367109	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4773356	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2021Q4	us-gaap	Goodwill Goodwill	6140465	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1367109	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	447500	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3024245	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1789366	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3024245	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2992473	USD
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	427228	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	401600	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	844324	USD
CY2021Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	2843415	USD
CY2020Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	4619579	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	18736131	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	15413925	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2765794	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2120457	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15970337	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13293468	USD
CY2020Q3	ela	New Retail Building NewRetailBuilding	1195000	USD
CY2020Q3	ela	Purchase Partly Financed PurchasePartlyFinanced	956000	USD
CY2020Q3	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.0365	pure
CY2020Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P20Y
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	5645	USD
CY2020Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	1670000	USD
CY2020Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.01	pure
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	18736131	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	140966078	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113922015	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	109744919	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	90853052	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6473561	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112808	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89618	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	10048875	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	6383943	USD
CY2021	us-gaap	Gross Profit GrossProfit	31221159	USD
CY2020	us-gaap	Gross Profit GrossProfit	23068963	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20798095	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15553274	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	926095	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	728626	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	21724190	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	16281900	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	9496969	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	6787063	USD
CY2021	ela	Gain On Loan Forgiveness GainOnLoanForgiveness	1668200	USD
CY2020	ela	Gain On Loan Forgiveness GainOnLoanForgiveness	0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-299435	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	306997	USD
CY2021	us-gaap	Interest Expense InterestExpense	704051	USD
CY2020	us-gaap	Interest Expense InterestExpense	620499	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10161683	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26924631	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26924631	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	15000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	15000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26939631	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26939631	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	15000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	112000	shares
CY2004Q2	us-gaap	Employee Stock Ownership Plan Esop Repurchase Obligation Amount EmployeeStockOwnershipPlanESOPRepurchaseObligationAmount	15000	USD
CY2016Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	1100000	USD
CY2020	us-gaap	Lease Cost LeaseCost	1452689	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.17
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.17
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.17
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.17
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.17
CY2021Q4	us-gaap	Investment Related Liabilities InvestmentRelatedLiabilities	15000	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	15000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28550	USD
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	4.07
CY2019Q4	us-gaap	Grants Receivable GrantsReceivable	1100000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.055	pure
CY2021	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	2300630	USD
CY2020	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	1314285	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2133953	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1364191	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1787132	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1371195	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3501	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	7004	USD
CY2021	ela	Ppp Loan Forgiveness PppLoanForgiveness	-350322	USD
CY2020	ela	Ppp Loan Forgiveness PppLoanForgiveness	0	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	112808	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	89618	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	112808	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	89618	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	112808	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	89618	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112808	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89618	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	39433	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	22620	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6836	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6836	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	224240	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	28580	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	297984	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	256065	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4500023	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	6527548	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	40945	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27085	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4513493	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6356604	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4513493	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6356604	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2729636	USD
CY2121Q4	ela	Net Deferred Tax Assets NetDeferredTaxAssets	4500000	USD
CY2021	ela	Net Operating Loss NetOperatingLoss	21400000	USD
CY2021	us-gaap	Lease Cost LeaseCost	2109104	USD
CY2021Q4	ela	Operating Lease Liability Subtotal OperatingLeaseLiabilitySubtotal	7446881	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1573824	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5873057	USD
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.15	pure
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.10	pure
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.06	pure

Files In Submission

Name	View Source	Status
0001654954-22-003269-index-headers.html	Edgar Link	pending
0001654954-22-003269-index.html	Edgar Link	pending
0001654954-22-003269.txt	Edgar Link	pending
0001654954-22-003269-xbrl.zip	Edgar Link	pending
ec_10kimg1.jpg	Edgar Link	pending
ela-20211231.xsd	Edgar Link	pending
ela-20211231_cal.xml	Edgar Link	unprocessable
ela-20211231_def.xml	Edgar Link	unprocessable
ela-20211231_lab.xml	Edgar Link	unprocessable
ela-20211231_pre.xml	Edgar Link	unprocessable
ela_10k.htm	Edgar Link	pending
ela_10k_htm.xml	Edgar Link	completed
ela_ex231.htm	Edgar Link	pending
ela_ex311.htm	Edgar Link	pending
ela_ex312.htm	Edgar Link	pending
ela_ex321.htm	Edgar Link	pending
ela_ex322.htm	Edgar Link	pending
ela_ex42.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELA
Envela Corp Stock $ela

2021 Q4 Form 10-K Financial Statement

#000165495422003269 Filed on March 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELA Envela Corp Stock $ela

2021 Q4 Form 10-K Financial Statement

#000165495422003269 Filed on March 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELA
Envela Corp Stock $ela